KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:CERC
Delisted

Cerecor Inc. Stock Price (Quote)

$0.319
+0.0060 (+1.92%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.202 $0.502 Friday, 27th May 2022 CERC stock ended at $0.319. This is 1.92% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 9.33% from a day low at $0.300 to a day high of $0.328.
90 days $0.202 $0.94
52 weeks $0.202 $3.70

Historical Cerecor Inc. prices

Date Open High Low Close Volume
Feb 29, 2016 $3.24 $3.28 $3.24 $3.26 12 700
Feb 26, 2016 $3.10 $3.22 $3.10 $3.20 5 900
Feb 25, 2016 $3.06 $3.09 $3.04 $3.09 5 400
Feb 24, 2016 $2.94 $3.06 $2.93 $3.01 5 800
Feb 23, 2016 $2.90 $3.07 $2.88 $3.00 16 400
Feb 22, 2016 $3.00 $3.05 $2.98 $3.04 7 300
Feb 19, 2016 $2.90 $3.05 $2.90 $3.00 20 600
Feb 18, 2016 $2.86 $3.10 $2.77 $3.01 40 500
Feb 17, 2016 $3.10 $3.10 $2.89 $3.10 16 800
Feb 16, 2016 $3.05 $3.05 $3.00 $3.02 13 500
Feb 12, 2016 $2.99 $3.01 $2.85 $2.91 18 800
Feb 11, 2016 $2.98 $3.08 $2.98 $3.08 2 700
Feb 10, 2016 $3.04 $3.09 $2.91 $3.05 21 700
Feb 09, 2016 $2.95 $2.98 $2.95 $2.98 1 900
Feb 08, 2016 $3.00 $3.05 $2.93 $3.03 3 400
Feb 05, 2016 $3.11 $3.11 $2.89 $2.97 4 700
Feb 04, 2016 $3.07 $3.08 $2.69 $3.00 30 400
Feb 03, 2016 $3.00 $3.14 $2.95 $3.02 20 400
Feb 02, 2016 $2.90 $3.12 $2.80 $3.00 35 900
Feb 01, 2016 $2.87 $2.97 $2.70 $2.90 19 400
Jan 29, 2016 $3.10 $3.16 $3.10 $3.14 5 100
Jan 28, 2016 $3.12 $3.19 $2.97 $3.10 22 700
Jan 27, 2016 $3.39 $3.39 $2.96 $2.96 23 900
Jan 26, 2016 $3.23 $3.38 $3.23 $3.34 16 000
Jan 25, 2016 $3.24 $3.29 $3.22 $3.25 4 100
Click to get the best stock tips daily for free!

About Cerecor Inc.

Cerecor. Cerecor Inc., a clinical-stage biopharmaceutical company, develops drugs to treat patients with neurological and psychiatric disorders. It develops CERC-301 that is in Phase II development stage for the adjunctive treatment of patients with major depressive disorder (MDD); CERC-501, which is in Phase II development stage for the adjunctive treatment of MDD, as well as to treat substance use disorders; and CERC-406 that is in preclinical stage to ... CERC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT